AT THE FOREFRONT OF BIOTECHNOLOGICAL INNOVATION IN PRODUCTS BASED ON 100% PURE MUSHROOMS
At Hifas da Terra, we are committed to innovation and scientific research, offering premium quality supplements and conducting preclinical and clinical trials, as well as other scientific studies.
We also explore new, patentable product categories based on our own mushroom strains.
Key data on R&D
We allocate 62% of our profits to R&D
More than 200 experts work with us. We collaborate with universities and research institutions.
We have our own scientific team and more than 200 collaborators from different disciplines. They include:
We are the Biotech Leader in Research and Development of Innovative Supplements, with more than 15 active studies which include clinical trials highly innovative linked to projects Micromarker and Microimmunomama. Likewise, other studies of great interest in other fundamental areas stand out.
Scientific and Biotechnological Innovation
Through innovation, we propose new processes and responsible protocols that positively impact people ...
We innovate in organic mushroom cultivation by introducing sustainable production in bioreactors, a pioneering system that allows mycelium to be cultivated under standardised conditions and expands applications of extracts by varying culture media, selecting specific strains geared towards results, etc. This system also allows us to more effectively isolate active biomolecules and new ingredients for our nutritional supplements.
We are laying the groundwork for what we call “tailored formulas”. We also carry out studies on our ingredients and on optimising our production processes.
The know-how of our R&D team opens the door to new patents based on mushrooms.
At Hifas da Terra we take part in, and start, research projects on mushrooms.
FUNFERMENT
PERTE 2024–2026
FUNFERMENT investigates the fermentation of selected agri-food by-products and the analytical characterisation of experimental ingredients developed through these processes.
Micromarker
2021 – 2024
Micromarker is a collaborative research project using clinical, analytical and multi-omics methods to collect data on the relationship between the gut microbiota and selected biological parameters.
Microimmunomama
2021 – 2024
Microinmunomama is a collaborative project involving the collection and analysis of gut-microbiota and immune-system parameters under a controlled research protocol.
AI-VIDDA
RIS3 2021–2027
AI-VIDDA brings together expertise in biotechnology, artificial intelligence and data analysis to develop and evaluate research tools relating to ageing and older populations.
NEW INGREDIENTS PRODUCTION
PERTE 2023–2025
AccelerEAT investigates the use of selected agri-food by-products in fermentation and other processes designed to support more circular and resource-efficient ingredient production.
Nutrigen 4.0
2021 – 2024
Nutrigen 4.0 explores how digital technologies and intelligent production systems can be applied to processes involving edible mushrooms from Galicia.
RESIDENTIAL-CARE OBSERVATIONAL STUDY
2020
This historical observational project collected real-world data in a residential-care setting during the public-health circumstances of 2020.
Research into Knee Function Assessments
2018
This observational project examined research methods used to collect participant-reported data about knee function, movement and everyday physical activities.
Neurofood
2018 – 2021
Neurofood explored structured methods for collecting research data across cognitive domains such as memory, attention, processing speed and visuospatial performance.
FUNGITECH
2019 – 2021
FungitechOnco included laboratory research into fungal-strain selection, controlled cultivation, analytical characterisation and in-vitro cell-culture methods.
Dismetasin
2018 – 2021
Dismetasine was an observational research project involving the collection and analysis of selected metabolic, nutritional and participant-reported measurements.